Investigation into Select Medical Board for Potential Fiduciary Breaches
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy SEM?
Source: Globenewswire
- Board Investigation: Brodsky & Smith law firm is investigating the Board of Directors of Select Medical Holdings Corporation for potential breaches of fiduciary duty related to the sale of the company for $16.50 per share, totaling an enterprise value of $3.9 billion, which may not provide fair value to shareholders.
- Transaction Value Dispute: The sale price is below Select Medical's 52-week high of $18.61 per share, raising concerns that the Board may have failed to act in the best interests of shareholders, thus questioning the fairness of the decision-making process.
- Legal Consultation Opportunity: Brodsky & Smith encourages shareholders of Select Medical to reach out for discussions on the legal implications of the investigation, indicating their willingness to provide no-obligation legal advice, which enhances shareholder awareness of their rights.
- Litigation Expertise: Brodsky & Smith has extensive experience in securities and class action lawsuits, having been appointed as lead counsel in numerous cases and successfully recovering millions for clients, demonstrating their capability in protecting shareholder interests.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SEM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SEM
Wall Street analysts forecast SEM stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 15.000
Low
17.00
Averages
18.75
High
21.00
Current: 15.000
Low
17.00
Averages
18.75
High
21.00
About SEM
Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
SELECT MEDICAL HOLDINGS CORP: TRANSACTION VALUED AT $3.9 BILLION
Company Overview: Selected Medical Holdings Corp is involved in the healthcare sector, focusing on providing medical services and solutions.
Valuation Details: The company is currently representing an enterprise value of $3.9 billion, indicating its market worth and financial standing.
See More
Consortium to Acquire Select Medical Holdings Corp Shares at $16.50 Each
Acquisition Announcement: Selected Medical Holdings Corp. has announced its intention to acquire Select Medical shares.
Purchase Price: The shares are being offered at a price of $16.50 per share.
See More
Ingram Micro Reports Strong Quarterly Earnings, Shares Surge
- Earnings Beat Expectations: Ingram Micro reported a quarterly adjusted EPS of 96 cents, surpassing the analyst consensus estimate of 88 cents, indicating strong profitability and boosting investor confidence.
- Sales Missed Targets: Despite the positive EPS, the company's quarterly sales were $14.878 billion, falling short of the analyst consensus of $14.073 billion, reflecting challenges in market demand that could impact future growth.
- Stock Price Surge: Following the earnings report, Ingram Micro's shares jumped 11.8% to $23.87, demonstrating a positive market reaction to the company's profitability, potentially attracting more investor interest.
- Overall Market Decline: While Ingram Micro performed well, the broader market saw a decline, with the Dow Jones index dropping over 1,100 points on Tuesday, indicating volatility in market sentiment that could negatively affect other stocks.
See More
Investigation into Select Medical Board for Potential Fiduciary Breaches
- Board Investigation: Brodsky & Smith law firm is investigating the Board of Directors of Select Medical Holdings Corporation for potential breaches of fiduciary duty related to the sale of the company for $16.50 per share, totaling an enterprise value of $3.9 billion, which may not provide fair value to shareholders.
- Transaction Value Dispute: The sale price is below Select Medical's 52-week high of $18.61 per share, raising concerns that the Board may have failed to act in the best interests of shareholders, thus questioning the fairness of the decision-making process.
- Legal Consultation Opportunity: Brodsky & Smith encourages shareholders of Select Medical to reach out for discussions on the legal implications of the investigation, indicating their willingness to provide no-obligation legal advice, which enhances shareholder awareness of their rights.
- Litigation Expertise: Brodsky & Smith has extensive experience in securities and class action lawsuits, having been appointed as lead counsel in numerous cases and successfully recovering millions for clients, demonstrating their capability in protecting shareholder interests.
See More
Select Medical Holdings to be Acquired, Shares Rise 8%
- Acquisition Agreement: Select Medical Holdings Corporation announced it will be acquired by a consortium led by Robert A. Ortenzio and Martin F. Jackson for $16.50 per share, valuing the company at approximately $3.9 billion, indicating strong market confidence in the deal.
- Significant Premium: The acquisition price represents an 18% premium over the unaffected share price as of November 24, 2025, and a 25% premium over its 90-day average closing price, reflecting the consortium's confidence in Select Medical's future prospects.
- Management Continuity: The deal was unanimously approved by Select Medical's independent board, with Ortenzio and Jackson opting to roll over their equity into the new parent company rather than cash out, demonstrating management's commitment to the company's future.
- Operational Stability: Select Medical will continue to operate normally during the merger process, with the current management team expected to remain in place, and existing debt will remain outstanding, simplifying the financing for the transaction.
See More
Select Medical Announces $3.9 Billion Acquisition Agreement
- Acquisition Agreement: Select Medical Holdings announced a definitive agreement for a $3.9 billion acquisition led by executive chairman Robert A. Ortenzio, offering $16.50 per share in cash, representing an approximately 18% premium over the unaffected share price.
- Stock Price Surge: Following the announcement, Select Medical's shares rose over 7% in after-hours trading, reflecting a positive market reaction to the acquisition news and indicating investor confidence in future growth prospects.
- Future Revenue Outlook: Select Medical anticipates revenue of up to $5.8 billion in 2026, suggesting that the company's inpatient rehab expansion plans are advancing, which could further enhance its market share.
- Transaction Timeline: The merger is expected to close in mid-2026 and is not subject to a financing condition, indicating the robustness of the deal and the certainty of execution.
See More
SELECT MEDICAL HOLDINGS CORP: TRANSACTION VALUED AT $3.9 BILLION
Company Overview: Selected Medical Holdings Corp is involved in the healthcare sector, focusing on providing medical services and solutions.
Valuation Details: The company is currently representing an enterprise value of $3.9 billion, indicating its market worth and financial standing.
See More
Consortium to Acquire Select Medical Holdings Corp Shares at $16.50 Each
Acquisition Announcement: Selected Medical Holdings Corp. has announced its intention to acquire Select Medical shares.
Purchase Price: The shares are being offered at a price of $16.50 per share.
See More
Ingram Micro Reports Strong Quarterly Earnings, Shares Surge
- Earnings Beat Expectations: Ingram Micro reported a quarterly adjusted EPS of 96 cents, surpassing the analyst consensus estimate of 88 cents, indicating strong profitability and boosting investor confidence.
- Sales Missed Targets: Despite the positive EPS, the company's quarterly sales were $14.878 billion, falling short of the analyst consensus of $14.073 billion, reflecting challenges in market demand that could impact future growth.
- Stock Price Surge: Following the earnings report, Ingram Micro's shares jumped 11.8% to $23.87, demonstrating a positive market reaction to the company's profitability, potentially attracting more investor interest.
- Overall Market Decline: While Ingram Micro performed well, the broader market saw a decline, with the Dow Jones index dropping over 1,100 points on Tuesday, indicating volatility in market sentiment that could negatively affect other stocks.
See More
Investigation into Select Medical Board for Potential Fiduciary Breaches
- Board Investigation: Brodsky & Smith law firm is investigating the Board of Directors of Select Medical Holdings Corporation for potential breaches of fiduciary duty related to the sale of the company for $16.50 per share, totaling an enterprise value of $3.9 billion, which may not provide fair value to shareholders.
- Transaction Value Dispute: The sale price is below Select Medical's 52-week high of $18.61 per share, raising concerns that the Board may have failed to act in the best interests of shareholders, thus questioning the fairness of the decision-making process.
- Legal Consultation Opportunity: Brodsky & Smith encourages shareholders of Select Medical to reach out for discussions on the legal implications of the investigation, indicating their willingness to provide no-obligation legal advice, which enhances shareholder awareness of their rights.
- Litigation Expertise: Brodsky & Smith has extensive experience in securities and class action lawsuits, having been appointed as lead counsel in numerous cases and successfully recovering millions for clients, demonstrating their capability in protecting shareholder interests.
See More
Select Medical Holdings to be Acquired, Shares Rise 8%
- Acquisition Agreement: Select Medical Holdings Corporation announced it will be acquired by a consortium led by Robert A. Ortenzio and Martin F. Jackson for $16.50 per share, valuing the company at approximately $3.9 billion, indicating strong market confidence in the deal.
- Significant Premium: The acquisition price represents an 18% premium over the unaffected share price as of November 24, 2025, and a 25% premium over its 90-day average closing price, reflecting the consortium's confidence in Select Medical's future prospects.
- Management Continuity: The deal was unanimously approved by Select Medical's independent board, with Ortenzio and Jackson opting to roll over their equity into the new parent company rather than cash out, demonstrating management's commitment to the company's future.
- Operational Stability: Select Medical will continue to operate normally during the merger process, with the current management team expected to remain in place, and existing debt will remain outstanding, simplifying the financing for the transaction.
See More
Select Medical Announces $3.9 Billion Acquisition Agreement
- Acquisition Agreement: Select Medical Holdings announced a definitive agreement for a $3.9 billion acquisition led by executive chairman Robert A. Ortenzio, offering $16.50 per share in cash, representing an approximately 18% premium over the unaffected share price.
- Stock Price Surge: Following the announcement, Select Medical's shares rose over 7% in after-hours trading, reflecting a positive market reaction to the acquisition news and indicating investor confidence in future growth prospects.
- Future Revenue Outlook: Select Medical anticipates revenue of up to $5.8 billion in 2026, suggesting that the company's inpatient rehab expansion plans are advancing, which could further enhance its market share.
- Transaction Timeline: The merger is expected to close in mid-2026 and is not subject to a financing condition, indicating the robustness of the deal and the certainty of execution.
See More
